News Quantified

SXTP – 60 degrees pharmaceuticals, inc. (US:NASDAQ)

60 Degrees Pharmaceuticals (SXTP) had its price target lowered by Ascendiant Capital Markets from $11.20 to $4.20. They now have a "buy" rating on the stock.

4/4

01:05 am

sxtp

Low

60 Degrees Pharmaceuticals (SXTP) was upgraded by Wall Street Zen fro

60 Degrees Pharmaceuticals Announces 2025 Annual Results [Yahoo! Finance]

60 Degrees Pharmaceuticals Announces 2025 Annual Results

60 Degrees Pharmaceuticals (SXTP) was upgraded by Wall Street Zen to

Live Event: Join our next subscriber-only event: "The Data Driven Investor"

Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com

Click Here To Register For The Live Online Workshop

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}